Stockscreener 앱 받기
0.8587
0.39%
-0.0034
전일 마감가:
$0.8621
열려 있는:
$0.878
하루 거래량:
57,510
Relative Volume:
0.59
시가총액:
$29.56M
수익:
-
순이익/손실:
-
주가수익비율:
-9.7358
EPS:
-0.0882
순현금흐름:
-
1주 성능:
-18.99%
1개월 성능:
-25.33%
6개월 성능:
-60.61%
1년 성능:
-79.89%
1일 변동 폭
$0.82
$0.89
1주일 범위
$0.7862
$1.09
52주 변동 폭
$0.51
$5.60
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
명칭
Jupiter Neurosciences Inc
전화
(561) 406-6154
주소
1001 NORTH US HWY 1, JUPITER
JUNS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
0.8587 | 29.68M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Jupiter Neurosciences Inc 주식(JUNS)의 최신 뉴스
Bull Bear: Will Jupiter Neurosciences Inc benefit from rising consumer demandQuarterly Earnings Report & Daily Chart Pattern Signals - baoquankhu1.vn
Market Pulse: Is Jupiter Neurosciences Inc forming a bullish divergenceQuarterly Portfolio Report & Safe Capital Investment Plans - baoquankhu1.vn
Investment Report: Is BioSig Technologies Incs growth already priced inIPO Watch & Growth Focused Entry Reports - baoquankhu1.vn
Aug Summary: What is the earnings history of Jupiter Neurosciences Inc2025 Trading Volume Trends & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Aug Weekly: Can Valley National Bancorp keep up with sector leadersForecast Cut & Real-Time Sentiment Analysis - baoquankhu1.vn
S P Trends: Why is Invesco Value Municipal Income Trust stock going downWeekly Trend Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Aug Patterns: Can Amdocs Limited reach all time highs this year2025 Key Lessons & Growth Oriented Trading Recommendations - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Why Jupiter Neurosciences Inc. stock remains on buy listsMarket Rally & Reliable Price Breakout Signals - Улправда
Can Jupiter Neurosciences Inc. stock maintain growth trajectory2025 Technical Overview & Expert Approved Momentum Ideas - Улправда
Why Jupiter Neurosciences Inc. stock is trending among retail tradersNew Guidance & Free AI Powered Buy and Sell Recommendations - Улправда
Will Jupiter Neurosciences Inc. stock benefit from AI adoptionEarnings Recap Summary & Free Verified High Yield Trade Plans - Улправда
How institutional buying supports Jupiter Neurosciences Inc. stockWeekly Trend Recap & Daily Volume Surge Signals - Улправда
Will Jupiter Neurosciences Inc. stock gain from lower inflationJuly 2025 Highlights & Free Reliable Trade Execution Plans - Улправда
Can Jupiter Neurosciences Inc. stock deliver strong Q4 earnings2025 Trading Volume Trends & Verified Stock Trade Ideas - Улправда
Aug Volume: Why Jupiter Neurosciences Inc stock is trending among retail tradersWeekly Trading Summary & Weekly Momentum Picks - Bộ Nội Vụ
Will Jupiter Neurosciences Inc. stock split again soonGlobal Trade Effects & High Return Wealth Building - Улправда
Jupiter Neurosciences expands equity financing through SEPA advances - MSN
What margin trends mean for Jupiter Neurosciences Inc. stockInflation Impact on Stocks & Small Investment Big Gains - bollywoodhelpline.com
Jupiter Neurosciences Expands Equity Financing Through SEPA Advances - TipRanks
Jupiter Neurosciences Signs Multiple Material Agreements - TradingView — Track All Markets
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6 - marketscreener.com
The best and worst-performing stocks of 2025 | 2025-12-22 | Investing News - Stockhouse
Jupiter Neurosciences Shareholders Approve Key Governance Measures - TipRanks
The best and worst-performing stocks of 2025 - MSN
New Highs: What margin trends mean for Jupiter Neurosciences Inc. stockJuly 2025 Gainers & Community Verified Trade Signals - moha.gov.vn
Stock Analysis: What margin trends mean for Jupiter Neurosciences Inc. stockMarket Sentiment Review & AI Enhanced Market Trend Forecasts - Улправда
Will Jupiter Neurosciences Inc. stock sustain high P E ratiosEarnings Performance Report & Technical Pattern Based Signals - Улправда
Fed Meeting: Can Jupiter Neurosciences Inc. stock maintain growth trajectoryJuly 2025 Rallies & Reliable Entry Point Trade Alerts - Улправда
Jupiter Neurosciences Achieves Regulatory and Commercial Milestones in First Year as Public Company - citybuzz -
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon | Corporate - EQS News
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon - NewMediaWire
Contact | Statesman-Examiner - FinancialContent
$50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq - Yahoo Finance
Jupiter Neurosciences Marks Transformational First Year as - GlobeNewswire
Why Jupiter Neurosciences Inc. stock attracts global investorsWeekly Profit Summary & Daily Chart Pattern Signals - Newser
Jupiter Neurosciences (NASDAQ: JUNS) to Join NobleCon21 Emerging Growth Equity Conference - Stock Titan
Published on: 2025-11-27 23:20:01 - moha.gov.vn
Jupiter Neurosciences files rospectus related to resale of up to 10 million shares of our common stock by selling stockholder - marketscreener.com
Jupiter Neurosciences Inc Stock Analysis and ForecastPortfolio Diversification Tips & Watch Expert Picks Before They Rally - earlytimes.in
How Jupiter Neurosciences Inc. stock reacts to global recession fearsTrade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
Will Jupiter Neurosciences Inc. stock deliver shareholder valueJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
How Jupiter Neurosciences Inc. stock benefits from strong dollar2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Is Jupiter Neurosciences Inc. stock overvalued by current metricsIndex Update & Weekly Breakout Stock Alerts - newser.com
A activity2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com
Jupiter Neurosciences Inc (JUNS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Jupiter Neurosciences Inc 주식 (JUNS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Silva Alison D. | Pres + Chief Business Officer |
Jul 01 '25 |
Buy |
1.03 |
750 |
772 |
112,777 |
| ROSEN CHRISTER | CEO and Chairman |
Jul 01 '25 |
Buy |
1.02 |
3,600 |
3,667 |
11,078,892 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
110,227 |
0 |
110,227 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 30 '25 |
Buy |
1.03 |
950 |
978 |
112,027 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 27 '25 |
Buy |
1.03 |
850 |
877 |
111,077 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 02 '25 |
Option Exercise |
0.00 |
973,466 |
0 |
11,067,476 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 30 '25 |
Buy |
1.02 |
7,650 |
7,810 |
11,075,292 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 27 '25 |
Buy |
1.06 |
166 |
176 |
11,067,642 |
4.73%
0.92%
자본화:
|
볼륨(24시간):